文献速递糖尿病肥胖与代谢综合征

针对减重干预以减少2型糖尿病心血管并发症:基于机器学习对Look AHEAD试验异质性治疗效应的分析

Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial.
PubMed 文献 · Lancet Diabetes Endocrinol · 2017-07-12

该研究对Look AHEAD试验进行事后分析,使用因果森林模型在训练集识别异质性治疗效应,并在测试集用Cox模型验证。结果显示,HbA1c≥6.8%或HbA1c<6.8%且SF-36一般健康评分≥48的参与者从强化减重干预中获益,绝对风险降低3.46%(95%CI 0.21-6.73%,p=0.038);而HbA1c<6.8%且SF-36评分<48者绝对风险增加7.41%(95%CI 0.60-14.22,p=0.003)。

要点

  • HbA1c≥6.8%或HbA1c<6.8%且SF-36一般健康评分≥48者,强化减重干预可减少心血管事件。
  • HbA1c<6.8%且SF-36一般健康评分<48者,强化减重干预反而增加心血管事件风险。
  • HbA1c和简短健康问卷可能识别从强化减重干预中获益的2型糖尿病患者。

核心结论

  • Look AHEAD中血糖控制中等或较差(HbA1c≥6.8%)者以及血糖控制良好(HbA1c<6.8%)且自报健康良好者从减重行为干预中避免心血管事件。
  • 血糖控制良好但自报一般健康差者(占15%)经历负性效应,使总体研究结果呈中性。

研究设计与样本

  • 对Look AHEAD随机对照试验的事后分析,使用因果森林模型在随机一半数据(训练集)识别异质性治疗效应。
  • 在剩余一半数据(测试集)应用Cox比例风险模型检验潜在异质性治疗效应。
  • 2001年8月22日至2004年4月30日入组5145例2型糖尿病患者,其中4901例纳入分析:2450例用于模型开发,2451例用于测试数据集。

主要发现

  • 测试数据集中,HbA1c≥6.8%或HbA1c<6.8%且SF-36一般健康评分≥48的2101例(86%)参与者:干预组主要结局事件167/1046(16%),对照组205/1055(19%),绝对风险降低3.46%(95%CI 0.21-6.73%,p=0.038),需治疗人数28.9,9.6年预防1例事件。
  • HbA1c<6.8%且SF-36一般健康评分<48的350例(14%)参与者:干预组主要结局事件27/171(16%),对照组15/179(8%),绝对风险增加7.41%(95%CI 0.60-14.22,p=0.003)。
  • 基线HbA1c和自报一般健康可区分从干预中差异获益的参与者。

临床怎么用

  • HbA1c和简短一般健康问卷可能识别可能从旨在减重的强化生活方式干预中获益的2型糖尿病患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Action for Health in Diabetes (Look AHEAD) trial investigated whether long-term cardiovascular disease morbidity and mortality could be reduced through a weight loss intervention among people with type 2 diabetes. Despite finding no significant reduction in cardiovascular events on average, it is possible that some subpopulations might have derived benefit. In this post-hoc analysis, we test the hypothesis that the overall neutral average treatment effect in the trial masked important heterogeneous treatment effects (HTEs) from intensive weight loss interventions. METHODS: We used causal forest modelling, which identifies HTEs, using a random half of the trial data (the training set). We applied Cox proportional hazards models to test the potential HTEs on the remaining half of the data (the testing set). The analysis was deemed exempt from review by the Columbia University Institutional Review Board, Protocol ID# AAAO3003. FINDINGS: Between Aug 22, 2001, and April 30, 2004, 5145 patients with type 2 diabetes were enrolled in the Look AHEAD randomised controlled trial, of whom 4901 were included in the The National Institute of Diabetes and Digestive and Kidney Diseases Repository and included in our analyses: 2450 for model development and 2451 in the testing dataset. Baseline HbA1c and self-reported general health distinguished participants who differentially benefited from the intervention. Cox models for the primary composite cardiovascular outcome revealed a number needed to treat of 28·9 to prevent 1 event over 9·6 years among participants with HbA1c 6·8% or higher, or both HbA1c less than 6·8% and Short Form Health Survey (SF-36) general health score of 48 or more (2101 [86%] of 2451 participants in the testing dataset; 167 [16%] of 1046 primary outcome events for intervention vs 205 [19%] of 1055 for control, absolute risk reduction of 3·46%, 95% CI 0·21-6·73%, p=0·038) By contrast, participants with HbA1c less than 6·8% and baseline SF-36 general health score of less than 48 (350 [14%] of 2451 participants in the testing data; 27 [16%] of 171 primary outcome events for intervention vs 15 [8%] of 179 primary outcome events for control) had an absolute risk increase of the primary outcome of 7·41% (0·60 to 14·22, p=0·003). INTERPRETATION: Look AHEAD participants with moderately or poorly controlled diabetes (HbA1c 6·8% or higher) and subjects with well controlled diabetes (HbA1c less than 6·8%) and good self-reported health (85% of the overall study population) averted cardiovascular events from a behavioural intervention aimed at weight loss. However, 15% of participants with well controlled diabetes and poor self-reported general health experienced negative effects that rendered the overall study outcome neutral. HbA1c and a short questionnaire on general health might identify people with type 2 diabetes likely to derive benefit from an intensive lifestyle intervention aimed at weight loss. FUNDING: None.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Baum A, Scarpa J, Bruzelius E, et al. Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial. Lancet Diabetes Endocrinol. 2017. PMID: 28711469. doi:10.1016/S2213-8587(17)30176-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。